nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADK—epilepsy syndrome	0.486	1	CbGaD
Adenosine—ADORA1—Gabapentin—epilepsy syndrome	0.234	1	CbGbCtD
Adenosine—ADORA2A—ganglion—epilepsy syndrome	0.00253	0.0846	CbGeAlD
Adenosine—ADORA1—ganglion—epilepsy syndrome	0.00219	0.0731	CbGeAlD
Adenosine—ADORA2A—forebrain—epilepsy syndrome	0.00106	0.0355	CbGeAlD
Adenosine—ADORA2A—telencephalon—epilepsy syndrome	0.000977	0.0326	CbGeAlD
Adenosine—ADK—forebrain—epilepsy syndrome	0.000954	0.0319	CbGeAlD
Adenosine—ADORA1—forebrain—epilepsy syndrome	0.000918	0.0307	CbGeAlD
Adenosine—ADK—telencephalon—epilepsy syndrome	0.000878	0.0293	CbGeAlD
Adenosine—ADORA1—telencephalon—epilepsy syndrome	0.000844	0.0282	CbGeAlD
Adenosine—ADORA2B—head—epilepsy syndrome	0.000731	0.0244	CbGeAlD
Adenosine—ADORA2B—nervous system—epilepsy syndrome	0.000693	0.0232	CbGeAlD
Adenosine—ADK—medulla oblongata—epilepsy syndrome	0.00069	0.023	CbGeAlD
Adenosine—ADORA2A—spinal cord—epilepsy syndrome	0.000685	0.0229	CbGeAlD
Adenosine—Adenosine triphosphate—AFG3L2—epilepsy syndrome	0.00067	0.156	CrCbGaD
Adenosine—ADA—head—epilepsy syndrome	0.000669	0.0223	CbGeAlD
Adenosine—ADORA2B—central nervous system—epilepsy syndrome	0.000668	0.0223	CbGeAlD
Adenosine—ADORA1—medulla oblongata—epilepsy syndrome	0.000663	0.0221	CbGeAlD
Adenosine—Vidarabine—ADK—epilepsy syndrome	0.000653	0.152	CrCbGaD
Adenosine—ADORA2B—cerebellum—epilepsy syndrome	0.000652	0.0218	CbGeAlD
Adenosine—Ribavirin—ADK—epilepsy syndrome	0.000645	0.15	CrCbGaD
Adenosine—ADA—nervous system—epilepsy syndrome	0.000634	0.0212	CbGeAlD
Adenosine—ADK—midbrain—epilepsy syndrome	0.00063	0.0211	CbGeAlD
Adenosine—ADK—spinal cord—epilepsy syndrome	0.000615	0.0205	CbGeAlD
Adenosine—ADA—central nervous system—epilepsy syndrome	0.000611	0.0204	CbGeAlD
Adenosine—ADORA2A—head—epilepsy syndrome	0.000609	0.0203	CbGeAlD
Adenosine—ADORA1—midbrain—epilepsy syndrome	0.000606	0.0202	CbGeAlD
Adenosine—ADORA1—spinal cord—epilepsy syndrome	0.000591	0.0198	CbGeAlD
Adenosine—ADORA2A—nervous system—epilepsy syndrome	0.000577	0.0193	CbGeAlD
Adenosine—ADORA2A—central nervous system—epilepsy syndrome	0.000555	0.0186	CbGeAlD
Adenosine—ADK—head—epilepsy syndrome	0.000547	0.0183	CbGeAlD
Adenosine—ADORA2A—cerebellum—epilepsy syndrome	0.000543	0.0181	CbGeAlD
Adenosine—ADORA2B—brain—epilepsy syndrome	0.00053	0.0177	CbGeAlD
Adenosine—DPP4—head—epilepsy syndrome	0.00053	0.0177	CbGeAlD
Adenosine—ADORA1—head—epilepsy syndrome	0.000525	0.0176	CbGeAlD
Adenosine—ADK—nervous system—epilepsy syndrome	0.000518	0.0173	CbGeAlD
Adenosine—DPP4—nervous system—epilepsy syndrome	0.000502	0.0168	CbGeAlD
Adenosine—ADK—central nervous system—epilepsy syndrome	0.000499	0.0167	CbGeAlD
Adenosine—ADORA1—nervous system—epilepsy syndrome	0.000498	0.0166	CbGeAlD
Adenosine—Cytarabine—NT5E—epilepsy syndrome	0.000492	0.114	CrCbGaD
Adenosine—ADK—cerebellum—epilepsy syndrome	0.000488	0.0163	CbGeAlD
Adenosine—ADA—brain—epilepsy syndrome	0.000485	0.0162	CbGeAlD
Adenosine—DPP4—central nervous system—epilepsy syndrome	0.000484	0.0162	CbGeAlD
Adenosine—ADORA1—central nervous system—epilepsy syndrome	0.00048	0.016	CbGeAlD
Adenosine—ADORA1—cerebellum—epilepsy syndrome	0.000469	0.0157	CbGeAlD
Adenosine—ADORA2A—brain—epilepsy syndrome	0.000441	0.0147	CbGeAlD
Adenosine—ADK—brain—epilepsy syndrome	0.000396	0.0132	CbGeAlD
Adenosine—DPP4—brain—epilepsy syndrome	0.000384	0.0128	CbGeAlD
Adenosine—ADORA1—brain—epilepsy syndrome	0.000381	0.0127	CbGeAlD
Adenosine—Adenosine monophosphate—ADK—epilepsy syndrome	0.000377	0.0878	CrCbGaD
Adenosine—Adenosine triphosphate—ADK—epilepsy syndrome	0.000327	0.0761	CrCbGaD
Adenosine—Glucosamine—MMP9—epilepsy syndrome	0.000214	0.0499	CrCbGaD
Adenosine—Glucosamine—TNF—epilepsy syndrome	0.000141	0.0328	CrCbGaD
Adenosine—Adenosine triphosphate—AKT1—epilepsy syndrome	0.000138	0.0321	CrCbGaD
Adenosine—Adenosine monophosphate—SRC—epilepsy syndrome	0.000136	0.0316	CrCbGaD
Adenosine—Tenofovir—ABCC2—epilepsy syndrome	0.000121	0.0282	CrCbGaD
Adenosine—Clofarabine—ABCG2—epilepsy syndrome	0.000119	0.0276	CrCbGaD
Adenosine—Glucosamine—CYP2C19—epilepsy syndrome	0.000107	0.025	CrCbGaD
Adenosine—Hypersensitivity—Vigabatrin—epilepsy syndrome	7.63e-05	0.000501	CcSEcCtD
Adenosine—Asthenia—Fosphenytoin—epilepsy syndrome	7.62e-05	0.0005	CcSEcCtD
Adenosine—Dyspnoea—Lamotrigine—epilepsy syndrome	7.6e-05	0.000499	CcSEcCtD
Adenosine—Angioedema—Valproic Acid—epilepsy syndrome	7.59e-05	0.000498	CcSEcCtD
Adenosine—Somnolence—Lamotrigine—epilepsy syndrome	7.58e-05	0.000498	CcSEcCtD
Adenosine—Pain—Carbamazepine—epilepsy syndrome	7.54e-05	0.000495	CcSEcCtD
Adenosine—Dizziness—Propofol—epilepsy syndrome	7.53e-05	0.000495	CcSEcCtD
Adenosine—Hypersensitivity—Diazepam—epilepsy syndrome	7.51e-05	0.000493	CcSEcCtD
Adenosine—Asthenia—Vigabatrin—epilepsy syndrome	7.43e-05	0.000488	CcSEcCtD
Adenosine—Urticaria—Clonazepam—epilepsy syndrome	7.39e-05	0.000485	CcSEcCtD
Adenosine—Tinnitus—Gabapentin—epilepsy syndrome	7.37e-05	0.000484	CcSEcCtD
Adenosine—Dizziness—Midazolam—epilepsy syndrome	7.37e-05	0.000484	CcSEcCtD
Adenosine—Tension—Pregabalin—epilepsy syndrome	7.37e-05	0.000484	CcSEcCtD
Adenosine—Dysgeusia—Pregabalin—epilepsy syndrome	7.35e-05	0.000483	CcSEcCtD
Adenosine—Urticaria—Phenytoin—epilepsy syndrome	7.34e-05	0.000482	CcSEcCtD
Adenosine—Cardiac disorder—Gabapentin—epilepsy syndrome	7.34e-05	0.000482	CcSEcCtD
Adenosine—Palpitations—Valproic Acid—epilepsy syndrome	7.34e-05	0.000482	CcSEcCtD
Adenosine—Asthenia—Diazepam—epilepsy syndrome	7.31e-05	0.00048	CcSEcCtD
Adenosine—Urticaria—Oxcarbazepine—epilepsy syndrome	7.3e-05	0.00048	CcSEcCtD
Adenosine—Pain—Lamotrigine—epilepsy syndrome	7.29e-05	0.000479	CcSEcCtD
Adenosine—Nervousness—Pregabalin—epilepsy syndrome	7.29e-05	0.000479	CcSEcCtD
Adenosine—Nausea—Acetazolamide—epilepsy syndrome	7.28e-05	0.000478	CcSEcCtD
Adenosine—Dizziness—Levetiracetam—epilepsy syndrome	7.28e-05	0.000478	CcSEcCtD
Adenosine—Back pain—Pregabalin—epilepsy syndrome	7.26e-05	0.000477	CcSEcCtD
Adenosine—Cough—Valproic Acid—epilepsy syndrome	7.24e-05	0.000476	CcSEcCtD
Adenosine—Vomiting—Propofol—epilepsy syndrome	7.24e-05	0.000476	CcSEcCtD
Adenosine—Rash—Propofol—epilepsy syndrome	7.18e-05	0.000472	CcSEcCtD
Adenosine—Dermatitis—Propofol—epilepsy syndrome	7.17e-05	0.000471	CcSEcCtD
Adenosine—Hypertension—Valproic Acid—epilepsy syndrome	7.17e-05	0.000471	CcSEcCtD
Adenosine—Headache—Propofol—epilepsy syndrome	7.13e-05	0.000469	CcSEcCtD
Adenosine—Mediastinal disorder—Gabapentin—epilepsy syndrome	7.13e-05	0.000468	CcSEcCtD
Adenosine—Hypersensitivity—Zonisamide—epilepsy syndrome	7.11e-05	0.000467	CcSEcCtD
Adenosine—Vomiting—Midazolam—epilepsy syndrome	7.08e-05	0.000465	CcSEcCtD
Adenosine—Asthenia—Felbamate—epilepsy syndrome	7.08e-05	0.000465	CcSEcCtD
Adenosine—Vision blurred—Pregabalin—epilepsy syndrome	7.07e-05	0.000464	CcSEcCtD
Adenosine—Chest pain—Valproic Acid—epilepsy syndrome	7.07e-05	0.000464	CcSEcCtD
Adenosine—Anxiety—Valproic Acid—epilepsy syndrome	7.04e-05	0.000463	CcSEcCtD
Adenosine—Tremor—Pregabalin—epilepsy syndrome	7.03e-05	0.000462	CcSEcCtD
Adenosine—Rash—Midazolam—epilepsy syndrome	7.03e-05	0.000461	CcSEcCtD
Adenosine—Dizziness—Fosphenytoin—epilepsy syndrome	7.02e-05	0.000461	CcSEcCtD
Adenosine—Dermatitis—Midazolam—epilepsy syndrome	7.02e-05	0.000461	CcSEcCtD
Adenosine—Urticaria—Carbamazepine—epilepsy syndrome	7.01e-05	0.00046	CcSEcCtD
Adenosine—Vomiting—Levetiracetam—epilepsy syndrome	7e-05	0.000459	CcSEcCtD
Adenosine—Discomfort—Valproic Acid—epilepsy syndrome	6.98e-05	0.000459	CcSEcCtD
Adenosine—Headache—Midazolam—epilepsy syndrome	6.98e-05	0.000458	CcSEcCtD
Adenosine—Rash—Levetiracetam—epilepsy syndrome	6.94e-05	0.000456	CcSEcCtD
Adenosine—Dermatitis—Levetiracetam—epilepsy syndrome	6.93e-05	0.000455	CcSEcCtD
Adenosine—Asthenia—Zonisamide—epilepsy syndrome	6.93e-05	0.000455	CcSEcCtD
Adenosine—Dry mouth—Valproic Acid—epilepsy syndrome	6.91e-05	0.000454	CcSEcCtD
Adenosine—Agitation—Pregabalin—epilepsy syndrome	6.9e-05	0.000453	CcSEcCtD
Adenosine—Headache—Levetiracetam—epilepsy syndrome	6.89e-05	0.000453	CcSEcCtD
Adenosine—Angioedema—Pregabalin—epilepsy syndrome	6.86e-05	0.00045	CcSEcCtD
Adenosine—Hypersensitivity—Clonazepam—epilepsy syndrome	6.86e-05	0.00045	CcSEcCtD
Adenosine—Dizziness—Vigabatrin—epilepsy syndrome	6.85e-05	0.00045	CcSEcCtD
Adenosine—Hypersensitivity—Phenytoin—epilepsy syndrome	6.81e-05	0.000447	CcSEcCtD
Adenosine—Cladribine—ABCG2—epilepsy syndrome	6.81e-05	0.0158	CrCbGaD
Adenosine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.78e-05	0.000445	CcSEcCtD
Adenosine—Urticaria—Lamotrigine—epilepsy syndrome	6.77e-05	0.000445	CcSEcCtD
Adenosine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.77e-05	0.000445	CcSEcCtD
Adenosine—Bradycardia—Topiramate—epilepsy syndrome	6.77e-05	0.000445	CcSEcCtD
Adenosine—Nausea—Propofol—epilepsy syndrome	6.76e-05	0.000444	CcSEcCtD
Adenosine—Tension—Gabapentin—epilepsy syndrome	6.75e-05	0.000443	CcSEcCtD
Adenosine—Vomiting—Fosphenytoin—epilepsy syndrome	6.75e-05	0.000443	CcSEcCtD
Adenosine—Dysgeusia—Gabapentin—epilepsy syndrome	6.74e-05	0.000443	CcSEcCtD
Adenosine—Dizziness—Diazepam—epilepsy syndrome	6.74e-05	0.000443	CcSEcCtD
Adenosine—Syncope—Pregabalin—epilepsy syndrome	6.73e-05	0.000442	CcSEcCtD
Adenosine—Rash—Fosphenytoin—epilepsy syndrome	6.7e-05	0.00044	CcSEcCtD
Adenosine—Dermatitis—Fosphenytoin—epilepsy syndrome	6.69e-05	0.000439	CcSEcCtD
Adenosine—Nervousness—Gabapentin—epilepsy syndrome	6.68e-05	0.000439	CcSEcCtD
Adenosine—Asthenia—Clonazepam—epilepsy syndrome	6.68e-05	0.000438	CcSEcCtD
Adenosine—Back pain—Gabapentin—epilepsy syndrome	6.66e-05	0.000437	CcSEcCtD
Adenosine—Headache—Fosphenytoin—epilepsy syndrome	6.65e-05	0.000437	CcSEcCtD
Adenosine—Palpitations—Pregabalin—epilepsy syndrome	6.63e-05	0.000436	CcSEcCtD
Adenosine—Asthenia—Phenytoin—epilepsy syndrome	6.63e-05	0.000435	CcSEcCtD
Adenosine—Nausea—Midazolam—epilepsy syndrome	6.62e-05	0.000435	CcSEcCtD
Adenosine—Hypoaesthesia—Topiramate—epilepsy syndrome	6.62e-05	0.000435	CcSEcCtD
Adenosine—Tachycardia—Valproic Acid—epilepsy syndrome	6.61e-05	0.000434	CcSEcCtD
Adenosine—Loss of consciousness—Pregabalin—epilepsy syndrome	6.6e-05	0.000433	CcSEcCtD
Adenosine—Asthenia—Oxcarbazepine—epilepsy syndrome	6.6e-05	0.000433	CcSEcCtD
Adenosine—Vomiting—Vigabatrin—epilepsy syndrome	6.58e-05	0.000432	CcSEcCtD
Adenosine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.55e-05	0.00043	CcSEcCtD
Adenosine—Cough—Pregabalin—epilepsy syndrome	6.55e-05	0.00043	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCC2—epilepsy syndrome	6.55e-05	0.0152	CrCbGaD
Adenosine—Nausea—Levetiracetam—epilepsy syndrome	6.54e-05	0.000429	CcSEcCtD
Adenosine—Rash—Vigabatrin—epilepsy syndrome	6.53e-05	0.000429	CcSEcCtD
Adenosine—Dizziness—Felbamate—epilepsy syndrome	6.52e-05	0.000428	CcSEcCtD
Adenosine—Dermatitis—Vigabatrin—epilepsy syndrome	6.52e-05	0.000428	CcSEcCtD
Adenosine—Convulsion—Pregabalin—epilepsy syndrome	6.5e-05	0.000427	CcSEcCtD
Adenosine—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.5e-05	0.000427	CcSEcCtD
Adenosine—Vision blurred—Gabapentin—epilepsy syndrome	6.49e-05	0.000426	CcSEcCtD
Adenosine—Headache—Vigabatrin—epilepsy syndrome	6.48e-05	0.000426	CcSEcCtD
Adenosine—Hypertension—Pregabalin—epilepsy syndrome	6.48e-05	0.000426	CcSEcCtD
Adenosine—Vomiting—Diazepam—epilepsy syndrome	6.48e-05	0.000425	CcSEcCtD
Adenosine—Tremor—Gabapentin—epilepsy syndrome	6.45e-05	0.000423	CcSEcCtD
Adenosine—Rash—Diazepam—epilepsy syndrome	6.43e-05	0.000422	CcSEcCtD
Adenosine—Dermatitis—Diazepam—epilepsy syndrome	6.42e-05	0.000422	CcSEcCtD
Adenosine—Chest pain—Pregabalin—epilepsy syndrome	6.39e-05	0.00042	CcSEcCtD
Adenosine—Dizziness—Zonisamide—epilepsy syndrome	6.38e-05	0.000419	CcSEcCtD
Adenosine—Headache—Diazepam—epilepsy syndrome	6.38e-05	0.000419	CcSEcCtD
Adenosine—Anxiety—Pregabalin—epilepsy syndrome	6.37e-05	0.000418	CcSEcCtD
Adenosine—Hypotension—Valproic Acid—epilepsy syndrome	6.33e-05	0.000416	CcSEcCtD
Adenosine—Asthenia—Carbamazepine—epilepsy syndrome	6.33e-05	0.000416	CcSEcCtD
Adenosine—Agitation—Gabapentin—epilepsy syndrome	6.32e-05	0.000415	CcSEcCtD
Adenosine—Discomfort—Pregabalin—epilepsy syndrome	6.31e-05	0.000415	CcSEcCtD
Adenosine—Nausea—Fosphenytoin—epilepsy syndrome	6.31e-05	0.000414	CcSEcCtD
Adenosine—Angioedema—Gabapentin—epilepsy syndrome	6.29e-05	0.000413	CcSEcCtD
Adenosine—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.28e-05	0.000413	CcSEcCtD
Adenosine—Vomiting—Felbamate—epilepsy syndrome	6.27e-05	0.000412	CcSEcCtD
Adenosine—Dry mouth—Pregabalin—epilepsy syndrome	6.25e-05	0.00041	CcSEcCtD
Adenosine—Rash—Felbamate—epilepsy syndrome	6.22e-05	0.000408	CcSEcCtD
Adenosine—Dermatitis—Felbamate—epilepsy syndrome	6.21e-05	0.000408	CcSEcCtD
Adenosine—Tinnitus—Topiramate—epilepsy syndrome	6.2e-05	0.000407	CcSEcCtD
Adenosine—Headache—Felbamate—epilepsy syndrome	6.18e-05	0.000406	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.17e-05	0.000405	CcSEcCtD
Adenosine—Flushing—Topiramate—epilepsy syndrome	6.17e-05	0.000405	CcSEcCtD
Adenosine—Cardiac disorder—Topiramate—epilepsy syndrome	6.17e-05	0.000405	CcSEcCtD
Adenosine—Syncope—Gabapentin—epilepsy syndrome	6.17e-05	0.000405	CcSEcCtD
Adenosine—Dizziness—Clonazepam—epilepsy syndrome	6.15e-05	0.000404	CcSEcCtD
Adenosine—Nausea—Vigabatrin—epilepsy syndrome	6.15e-05	0.000404	CcSEcCtD
Adenosine—Vomiting—Zonisamide—epilepsy syndrome	6.14e-05	0.000403	CcSEcCtD
Adenosine—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.13e-05	0.000402	CcSEcCtD
Adenosine—Asthenia—Lamotrigine—epilepsy syndrome	6.12e-05	0.000402	CcSEcCtD
Adenosine—Dizziness—Phenytoin—epilepsy syndrome	6.11e-05	0.000401	CcSEcCtD
Adenosine—Rash—Zonisamide—epilepsy syndrome	6.09e-05	0.0004	CcSEcCtD
Adenosine—Paraesthesia—Valproic Acid—epilepsy syndrome	6.08e-05	0.0004	CcSEcCtD
Adenosine—Palpitations—Gabapentin—epilepsy syndrome	6.08e-05	0.000399	CcSEcCtD
Adenosine—Dermatitis—Zonisamide—epilepsy syndrome	6.08e-05	0.000399	CcSEcCtD
Adenosine—Dizziness—Oxcarbazepine—epilepsy syndrome	6.08e-05	0.000399	CcSEcCtD
Adenosine—Nausea—Diazepam—epilepsy syndrome	6.05e-05	0.000398	CcSEcCtD
Adenosine—Loss of consciousness—Gabapentin—epilepsy syndrome	6.05e-05	0.000397	CcSEcCtD
Adenosine—Headache—Zonisamide—epilepsy syndrome	6.05e-05	0.000397	CcSEcCtD
Adenosine—Dyspnoea—Valproic Acid—epilepsy syndrome	6.04e-05	0.000397	CcSEcCtD
Adenosine—Shock—Pregabalin—epilepsy syndrome	6.03e-05	0.000396	CcSEcCtD
Adenosine—Somnolence—Valproic Acid—epilepsy syndrome	6.02e-05	0.000396	CcSEcCtD
Adenosine—Cough—Gabapentin—epilepsy syndrome	6.01e-05	0.000394	CcSEcCtD
Adenosine—Mediastinal disorder—Topiramate—epilepsy syndrome	5.99e-05	0.000394	CcSEcCtD
Adenosine—Tachycardia—Pregabalin—epilepsy syndrome	5.98e-05	0.000393	CcSEcCtD
Adenosine—Convulsion—Gabapentin—epilepsy syndrome	5.96e-05	0.000392	CcSEcCtD
Adenosine—Hypertension—Gabapentin—epilepsy syndrome	5.94e-05	0.00039	CcSEcCtD
Adenosine—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.92e-05	0.000389	CcSEcCtD
Adenosine—Vomiting—Clonazepam—epilepsy syndrome	5.92e-05	0.000389	CcSEcCtD
Adenosine—Vomiting—Phenytoin—epilepsy syndrome	5.88e-05	0.000386	CcSEcCtD
Adenosine—Rash—Clonazepam—epilepsy syndrome	5.87e-05	0.000385	CcSEcCtD
Adenosine—Dermatitis—Clonazepam—epilepsy syndrome	5.86e-05	0.000385	CcSEcCtD
Adenosine—Chest pain—Gabapentin—epilepsy syndrome	5.86e-05	0.000385	CcSEcCtD
Adenosine—Nausea—Felbamate—epilepsy syndrome	5.86e-05	0.000385	CcSEcCtD
Adenosine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.85e-05	0.000384	CcSEcCtD
Adenosine—Anxiety—Gabapentin—epilepsy syndrome	5.84e-05	0.000383	CcSEcCtD
Adenosine—Dizziness—Carbamazepine—epilepsy syndrome	5.83e-05	0.000383	CcSEcCtD
Adenosine—Headache—Clonazepam—epilepsy syndrome	5.83e-05	0.000383	CcSEcCtD
Adenosine—Rash—Phenytoin—epilepsy syndrome	5.83e-05	0.000383	CcSEcCtD
Adenosine—Dermatitis—Phenytoin—epilepsy syndrome	5.82e-05	0.000382	CcSEcCtD
Adenosine—Rash—Oxcarbazepine—epilepsy syndrome	5.8e-05	0.000381	CcSEcCtD
Adenosine—Pain—Valproic Acid—epilepsy syndrome	5.79e-05	0.00038	CcSEcCtD
Adenosine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.79e-05	0.00038	CcSEcCtD
Adenosine—Headache—Phenytoin—epilepsy syndrome	5.79e-05	0.00038	CcSEcCtD
Adenosine—Discomfort—Gabapentin—epilepsy syndrome	5.79e-05	0.00038	CcSEcCtD
Adenosine—Headache—Oxcarbazepine—epilepsy syndrome	5.76e-05	0.000378	CcSEcCtD
Adenosine—Nausea—Zonisamide—epilepsy syndrome	5.73e-05	0.000377	CcSEcCtD
Adenosine—Dry mouth—Gabapentin—epilepsy syndrome	5.73e-05	0.000376	CcSEcCtD
Adenosine—Hypotension—Pregabalin—epilepsy syndrome	5.72e-05	0.000376	CcSEcCtD
Adenosine—Tension—Topiramate—epilepsy syndrome	5.68e-05	0.000373	CcSEcCtD
Adenosine—Dysgeusia—Topiramate—epilepsy syndrome	5.67e-05	0.000372	CcSEcCtD
Adenosine—Dizziness—Lamotrigine—epilepsy syndrome	5.64e-05	0.00037	CcSEcCtD
Adenosine—Nervousness—Topiramate—epilepsy syndrome	5.62e-05	0.000369	CcSEcCtD
Adenosine—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.62e-05	0.000369	CcSEcCtD
Adenosine—Vomiting—Carbamazepine—epilepsy syndrome	5.61e-05	0.000368	CcSEcCtD
Adenosine—Back pain—Topiramate—epilepsy syndrome	5.6e-05	0.000368	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.58e-05	0.000366	CcSEcCtD
Adenosine—Rash—Carbamazepine—epilepsy syndrome	5.56e-05	0.000365	CcSEcCtD
Adenosine—Dermatitis—Carbamazepine—epilepsy syndrome	5.56e-05	0.000365	CcSEcCtD
Adenosine—Nausea—Clonazepam—epilepsy syndrome	5.53e-05	0.000363	CcSEcCtD
Adenosine—Headache—Carbamazepine—epilepsy syndrome	5.53e-05	0.000363	CcSEcCtD
Adenosine—Shock—Gabapentin—epilepsy syndrome	5.53e-05	0.000363	CcSEcCtD
Adenosine—Paraesthesia—Pregabalin—epilepsy syndrome	5.5e-05	0.000361	CcSEcCtD
Adenosine—Nausea—Phenytoin—epilepsy syndrome	5.49e-05	0.000361	CcSEcCtD
Adenosine—Tachycardia—Gabapentin—epilepsy syndrome	5.48e-05	0.00036	CcSEcCtD
Adenosine—Dyspnoea—Pregabalin—epilepsy syndrome	5.46e-05	0.000359	CcSEcCtD
Adenosine—Nausea—Oxcarbazepine—epilepsy syndrome	5.46e-05	0.000359	CcSEcCtD
Adenosine—Vision blurred—Topiramate—epilepsy syndrome	5.46e-05	0.000358	CcSEcCtD
Adenosine—Somnolence—Pregabalin—epilepsy syndrome	5.45e-05	0.000358	CcSEcCtD
Adenosine—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.43e-05	0.000357	CcSEcCtD
Adenosine—Tremor—Topiramate—epilepsy syndrome	5.42e-05	0.000356	CcSEcCtD
Adenosine—Vomiting—Lamotrigine—epilepsy syndrome	5.42e-05	0.000356	CcSEcCtD
Adenosine—Urticaria—Valproic Acid—epilepsy syndrome	5.38e-05	0.000353	CcSEcCtD
Adenosine—Rash—Lamotrigine—epilepsy syndrome	5.38e-05	0.000353	CcSEcCtD
Adenosine—Dermatitis—Lamotrigine—epilepsy syndrome	5.37e-05	0.000353	CcSEcCtD
Adenosine—Headache—Lamotrigine—epilepsy syndrome	5.34e-05	0.000351	CcSEcCtD
Adenosine—Agitation—Topiramate—epilepsy syndrome	5.32e-05	0.000349	CcSEcCtD
Adenosine—Hypotension—Gabapentin—epilepsy syndrome	5.25e-05	0.000345	CcSEcCtD
Adenosine—Nausea—Carbamazepine—epilepsy syndrome	5.24e-05	0.000344	CcSEcCtD
Adenosine—Pain—Pregabalin—epilepsy syndrome	5.24e-05	0.000344	CcSEcCtD
Adenosine—Syncope—Topiramate—epilepsy syndrome	5.19e-05	0.000341	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.12e-05	0.000336	CcSEcCtD
Adenosine—Palpitations—Topiramate—epilepsy syndrome	5.12e-05	0.000336	CcSEcCtD
Adenosine—Loss of consciousness—Topiramate—epilepsy syndrome	5.09e-05	0.000334	CcSEcCtD
Adenosine—Nausea—Lamotrigine—epilepsy syndrome	5.06e-05	0.000333	CcSEcCtD
Adenosine—Cough—Topiramate—epilepsy syndrome	5.05e-05	0.000332	CcSEcCtD
Adenosine—Paraesthesia—Gabapentin—epilepsy syndrome	5.04e-05	0.000331	CcSEcCtD
Adenosine—Convulsion—Topiramate—epilepsy syndrome	5.02e-05	0.000329	CcSEcCtD
Adenosine—Dyspnoea—Gabapentin—epilepsy syndrome	5.01e-05	0.000329	CcSEcCtD
Adenosine—Hypertension—Topiramate—epilepsy syndrome	5e-05	0.000328	CcSEcCtD
Adenosine—Somnolence—Gabapentin—epilepsy syndrome	4.99e-05	0.000328	CcSEcCtD
Adenosine—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.99e-05	0.000328	CcSEcCtD
Adenosine—Chest pain—Topiramate—epilepsy syndrome	4.93e-05	0.000324	CcSEcCtD
Adenosine—Anxiety—Topiramate—epilepsy syndrome	4.91e-05	0.000323	CcSEcCtD
Adenosine—Discomfort—Topiramate—epilepsy syndrome	4.87e-05	0.00032	CcSEcCtD
Adenosine—Urticaria—Pregabalin—epilepsy syndrome	4.87e-05	0.00032	CcSEcCtD
Adenosine—Asthenia—Valproic Acid—epilepsy syndrome	4.86e-05	0.000319	CcSEcCtD
Adenosine—Dry mouth—Topiramate—epilepsy syndrome	4.82e-05	0.000317	CcSEcCtD
Adenosine—Pain—Gabapentin—epilepsy syndrome	4.8e-05	0.000315	CcSEcCtD
Adenosine—Shock—Topiramate—epilepsy syndrome	4.65e-05	0.000305	CcSEcCtD
Adenosine—Tachycardia—Topiramate—epilepsy syndrome	4.61e-05	0.000303	CcSEcCtD
Adenosine—Hyperhidrosis—Topiramate—epilepsy syndrome	4.57e-05	0.0003	CcSEcCtD
Adenosine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.51e-05	0.000296	CcSEcCtD
Adenosine—Dizziness—Valproic Acid—epilepsy syndrome	4.48e-05	0.000294	CcSEcCtD
Adenosine—Urticaria—Gabapentin—epilepsy syndrome	4.46e-05	0.000293	CcSEcCtD
Adenosine—Hypotension—Topiramate—epilepsy syndrome	4.42e-05	0.00029	CcSEcCtD
Adenosine—Asthenia—Pregabalin—epilepsy syndrome	4.39e-05	0.000289	CcSEcCtD
Adenosine—Vomiting—Valproic Acid—epilepsy syndrome	4.31e-05	0.000283	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.31e-05	0.000283	CcSEcCtD
Adenosine—Rash—Valproic Acid—epilepsy syndrome	4.27e-05	0.000281	CcSEcCtD
Adenosine—Dermatitis—Valproic Acid—epilepsy syndrome	4.27e-05	0.00028	CcSEcCtD
Adenosine—Headache—Valproic Acid—epilepsy syndrome	4.24e-05	0.000279	CcSEcCtD
Adenosine—Paraesthesia—Topiramate—epilepsy syndrome	4.24e-05	0.000279	CcSEcCtD
Adenosine—Dyspnoea—Topiramate—epilepsy syndrome	4.21e-05	0.000277	CcSEcCtD
Adenosine—Somnolence—Topiramate—epilepsy syndrome	4.2e-05	0.000276	CcSEcCtD
Adenosine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.14e-05	0.000272	CcSEcCtD
Adenosine—Dizziness—Pregabalin—epilepsy syndrome	4.05e-05	0.000266	CcSEcCtD
Adenosine—Pain—Topiramate—epilepsy syndrome	4.04e-05	0.000265	CcSEcCtD
Adenosine—Asthenia—Gabapentin—epilepsy syndrome	4.03e-05	0.000265	CcSEcCtD
Adenosine—Nausea—Valproic Acid—epilepsy syndrome	4.02e-05	0.000264	CcSEcCtD
Adenosine—Vomiting—Pregabalin—epilepsy syndrome	3.89e-05	0.000256	CcSEcCtD
Adenosine—Rash—Pregabalin—epilepsy syndrome	3.86e-05	0.000254	CcSEcCtD
Adenosine—Dermatitis—Pregabalin—epilepsy syndrome	3.86e-05	0.000253	CcSEcCtD
Adenosine—Headache—Pregabalin—epilepsy syndrome	3.84e-05	0.000252	CcSEcCtD
Adenosine—Urticaria—Topiramate—epilepsy syndrome	3.75e-05	0.000247	CcSEcCtD
Adenosine—Dizziness—Gabapentin—epilepsy syndrome	3.71e-05	0.000244	CcSEcCtD
Adenosine—Nausea—Pregabalin—epilepsy syndrome	3.64e-05	0.000239	CcSEcCtD
Adenosine—Vomiting—Gabapentin—epilepsy syndrome	3.57e-05	0.000235	CcSEcCtD
Adenosine—Rash—Gabapentin—epilepsy syndrome	3.54e-05	0.000233	CcSEcCtD
Adenosine—Dermatitis—Gabapentin—epilepsy syndrome	3.54e-05	0.000232	CcSEcCtD
Adenosine—Headache—Gabapentin—epilepsy syndrome	3.52e-05	0.000231	CcSEcCtD
Adenosine—Hypersensitivity—Topiramate—epilepsy syndrome	3.48e-05	0.000229	CcSEcCtD
Adenosine—Asthenia—Topiramate—epilepsy syndrome	3.39e-05	0.000223	CcSEcCtD
Adenosine—Nausea—Gabapentin—epilepsy syndrome	3.34e-05	0.000219	CcSEcCtD
Adenosine—Dizziness—Topiramate—epilepsy syndrome	3.12e-05	0.000205	CcSEcCtD
Adenosine—Vomiting—Topiramate—epilepsy syndrome	3e-05	0.000197	CcSEcCtD
Adenosine—Rash—Topiramate—epilepsy syndrome	2.98e-05	0.000196	CcSEcCtD
Adenosine—Dermatitis—Topiramate—epilepsy syndrome	2.98e-05	0.000195	CcSEcCtD
Adenosine—Headache—Topiramate—epilepsy syndrome	2.96e-05	0.000194	CcSEcCtD
Adenosine—Nausea—Topiramate—epilepsy syndrome	2.81e-05	0.000184	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCB1—epilepsy syndrome	2.41e-05	0.0056	CrCbGaD
Adenosine—ADORA2B—Signaling Pathways—OXT—epilepsy syndrome	1.42e-05	0.000152	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL2—epilepsy syndrome	1.42e-05	0.000152	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL3—epilepsy syndrome	1.42e-05	0.000152	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—HTR7—epilepsy syndrome	1.42e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCR5—epilepsy syndrome	1.4e-05	0.00015	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AVP—epilepsy syndrome	1.4e-05	0.00015	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—POMC—epilepsy syndrome	1.4e-05	0.00015	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.4e-05	0.000149	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRH3—epilepsy syndrome	1.38e-05	0.000148	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HTR2A—epilepsy syndrome	1.37e-05	0.000147	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL2—epilepsy syndrome	1.37e-05	0.000147	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GNAO1—epilepsy syndrome	1.37e-05	0.000146	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—OPRD1—epilepsy syndrome	1.37e-05	0.000146	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—OPRM1—epilepsy syndrome	1.36e-05	0.000145	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT3—epilepsy syndrome	1.35e-05	0.000144	CbGpPWpGaD
Adenosine—ADA—Metabolism—HMOX1—epilepsy syndrome	1.35e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL12—epilepsy syndrome	1.34e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.34e-05	0.000144	CbGpPWpGaD
Adenosine—ADA—Metabolism—CAT—epilepsy syndrome	1.33e-05	0.000142	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.33e-05	0.000142	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TSC1—epilepsy syndrome	1.32e-05	0.000141	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTK2B—epilepsy syndrome	1.32e-05	0.000141	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CNR1—epilepsy syndrome	1.32e-05	0.000141	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PLCB1—epilepsy syndrome	1.32e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.31e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR7—epilepsy syndrome	1.31e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GRM1—epilepsy syndrome	1.31e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CHRM1—epilepsy syndrome	1.31e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PDYN—epilepsy syndrome	1.31e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AGT—epilepsy syndrome	1.3e-05	0.000139	CbGpPWpGaD
Adenosine—ADK—Metabolism—POMC—epilepsy syndrome	1.3e-05	0.000139	CbGpPWpGaD
Adenosine—ADA—Metabolism—ABCB1—epilepsy syndrome	1.29e-05	0.000138	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HTR7—epilepsy syndrome	1.29e-05	0.000137	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCR2—epilepsy syndrome	1.29e-05	0.000137	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NTRK2—epilepsy syndrome	1.29e-05	0.000137	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SST—epilepsy syndrome	1.29e-05	0.000137	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR3—epilepsy syndrome	1.29e-05	0.000137	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.29e-05	0.000137	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—SRC—epilepsy syndrome	1.28e-05	0.000136	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—DUSP6—epilepsy syndrome	1.28e-05	0.000136	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.26e-05	0.000134	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PLAT—epilepsy syndrome	1.25e-05	0.000134	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NPY—epilepsy syndrome	1.25e-05	0.000134	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.25e-05	0.000134	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HBEGF—epilepsy syndrome	1.25e-05	0.000133	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CDC42—epilepsy syndrome	1.23e-05	0.000132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GFAP—epilepsy syndrome	1.23e-05	0.000132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GAL—epilepsy syndrome	1.23e-05	0.000132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT3—epilepsy syndrome	1.23e-05	0.000131	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AGT—epilepsy syndrome	1.22e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP2—epilepsy syndrome	1.22e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CHRM3—epilepsy syndrome	1.22e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GRM5—epilepsy syndrome	1.22e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.21e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL12—epilepsy syndrome	1.21e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HSPB1—epilepsy syndrome	1.21e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL3—epilepsy syndrome	1.21e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CRH—epilepsy syndrome	1.21e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL2—epilepsy syndrome	1.21e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—OXT—epilepsy syndrome	1.21e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—POMC—epilepsy syndrome	1.21e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.2e-05	0.000129	CbGpPWpGaD
Adenosine—ADA—Metabolism—GPX1—epilepsy syndrome	1.2e-05	0.000128	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.2e-05	0.000128	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCR5—epilepsy syndrome	1.19e-05	0.000127	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AVP—epilepsy syndrome	1.19e-05	0.000127	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALB—epilepsy syndrome	1.19e-05	0.000127	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUNB—epilepsy syndrome	1.19e-05	0.000127	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CNR1—epilepsy syndrome	1.19e-05	0.000127	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PLCB1—epilepsy syndrome	1.18e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CX3CR1—epilepsy syndrome	1.17e-05	0.000125	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.17e-05	0.000125	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HTR7—epilepsy syndrome	1.16e-05	0.000124	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BDKRB1—epilepsy syndrome	1.15e-05	0.000122	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CHRM2—epilepsy syndrome	1.15e-05	0.000122	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CX3CL1—epilepsy syndrome	1.15e-05	0.000122	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.13e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HBEGF—epilepsy syndrome	1.12e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TSC1—epilepsy syndrome	1.12e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTK2B—epilepsy syndrome	1.12e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CDC42—epilepsy syndrome	1.12e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GABBR1—epilepsy syndrome	1.11e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AGT—epilepsy syndrome	1.11e-05	0.000118	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT3—epilepsy syndrome	1.1e-05	0.000118	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—POMC—epilepsy syndrome	1.1e-05	0.000117	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SST—epilepsy syndrome	1.09e-05	0.000117	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NTRK2—epilepsy syndrome	1.09e-05	0.000117	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR2—epilepsy syndrome	1.09e-05	0.000117	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—DUSP6—epilepsy syndrome	1.08e-05	0.000116	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AVP—epilepsy syndrome	1.08e-05	0.000116	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADAM10—epilepsy syndrome	1.08e-05	0.000115	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL2—epilepsy syndrome	1.07e-05	0.000115	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.07e-05	0.000114	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRH3—epilepsy syndrome	1.07e-05	0.000114	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PLAT—epilepsy syndrome	1.07e-05	0.000114	CbGpPWpGaD
Adenosine—ADA—Metabolism—AGT—epilepsy syndrome	1.05e-05	0.000112	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—OPRM1—epilepsy syndrome	1.05e-05	0.000112	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—epilepsy syndrome	1.04e-05	0.000111	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—epilepsy syndrome	1.03e-05	0.00011	CbGpPWpGaD
Adenosine—ADA—Metabolism—APOE—epilepsy syndrome	1.03e-05	0.00011	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL12—epilepsy syndrome	1.03e-05	0.00011	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.03e-05	0.00011	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—POMC—epilepsy syndrome	1.03e-05	0.00011	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.02e-05	0.000109	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.02e-05	0.000109	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—S100B—epilepsy syndrome	1.02e-05	0.000109	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.01e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SOCS3—epilepsy syndrome	1.01e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUNB—epilepsy syndrome	1.01e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CNR1—epilepsy syndrome	1.01e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDC42—epilepsy syndrome	1.01e-05	0.000108	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PLCB1—epilepsy syndrome	1.01e-05	0.000107	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR3—epilepsy syndrome	9.94e-06	0.000106	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.93e-06	0.000106	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HTR7—epilepsy syndrome	9.85e-06	0.000105	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AVP—epilepsy syndrome	9.75e-06	0.000104	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NPY—epilepsy syndrome	9.68e-06	0.000103	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	9.68e-06	0.000103	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HBEGF—epilepsy syndrome	9.56e-06	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AGT—epilepsy syndrome	9.42e-06	0.000101	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT3—epilepsy syndrome	9.39e-06	0.0001	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HSPB1—epilepsy syndrome	9.34e-06	9.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL2—epilepsy syndrome	9.34e-06	9.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CRH—epilepsy syndrome	9.34e-06	9.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—OXT—epilepsy syndrome	9.34e-06	9.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL3—epilepsy syndrome	9.34e-06	9.97e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—POMC—epilepsy syndrome	9.33e-06	9.96e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HES1—epilepsy syndrome	9.22e-06	9.84e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCR5—epilepsy syndrome	9.22e-06	9.84e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADAM10—epilepsy syndrome	9.17e-06	9.79e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL2—epilepsy syndrome	9.13e-06	9.74e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	9.02e-06	9.63e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FYN—epilepsy syndrome	8.97e-06	9.57e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—H2AFX—epilepsy syndrome	8.94e-06	9.54e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MEF2C—epilepsy syndrome	8.92e-06	9.52e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—POMC—epilepsy syndrome	8.86e-06	9.46e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.71e-06	9.29e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TSC1—epilepsy syndrome	8.69e-06	9.27e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTK2B—epilepsy syndrome	8.69e-06	9.27e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—S100B—epilepsy syndrome	8.67e-06	9.25e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	8.62e-06	9.2e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SOCS3—epilepsy syndrome	8.59e-06	9.16e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDC42—epilepsy syndrome	8.57e-06	9.14e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AGT—epilepsy syndrome	8.56e-06	9.13e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NGF—epilepsy syndrome	8.52e-06	9.1e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NTRK2—epilepsy syndrome	8.45e-06	9.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR2—epilepsy syndrome	8.45e-06	9.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SST—epilepsy syndrome	8.45e-06	9.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DUSP6—epilepsy syndrome	8.37e-06	8.94e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCR5—epilepsy syndrome	8.29e-06	8.85e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AVP—epilepsy syndrome	8.29e-06	8.85e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADRA2A—epilepsy syndrome	8.27e-06	8.82e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PLAT—epilepsy syndrome	8.23e-06	8.79e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HTR2A—epilepsy syndrome	8.12e-06	8.66e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALB—epilepsy syndrome	8.08e-06	8.62e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL12—epilepsy syndrome	7.94e-06	8.48e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	7.94e-06	8.48e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—epilepsy syndrome	7.94e-06	8.48e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—POMC—epilepsy syndrome	7.93e-06	8.47e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	7.91e-06	8.44e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	7.88e-06	8.41e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HES1—epilepsy syndrome	7.84e-06	8.37e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CNR1—epilepsy syndrome	7.8e-06	8.32e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUNB—epilepsy syndrome	7.8e-06	8.32e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PLCB1—epilepsy syndrome	7.77e-06	8.29e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TSC2—epilepsy syndrome	7.71e-06	8.23e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AGT—epilepsy syndrome	7.7e-06	8.22e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FYN—epilepsy syndrome	7.63e-06	8.14e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HTR7—epilepsy syndrome	7.61e-06	8.12e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—H2AFX—epilepsy syndrome	7.6e-06	8.11e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MEF2C—epilepsy syndrome	7.58e-06	8.1e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOE—epilepsy syndrome	7.54e-06	8.05e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KDR—epilepsy syndrome	7.39e-06	7.89e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HBEGF—epilepsy syndrome	7.38e-06	7.88e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.33e-06	7.82e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT3—epilepsy syndrome	7.25e-06	7.74e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NGF—epilepsy syndrome	7.25e-06	7.74e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—POMC—epilepsy syndrome	7.2e-06	7.69e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PRKCB—epilepsy syndrome	7.11e-06	7.59e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6ST—epilepsy syndrome	7.09e-06	7.56e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADAM10—epilepsy syndrome	7.08e-06	7.56e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—epilepsy syndrome	7.07e-06	7.54e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR5—epilepsy syndrome	7.05e-06	7.53e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL2—epilepsy syndrome	7.05e-06	7.52e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HTR2A—epilepsy syndrome	6.9e-06	7.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—S100B—epilepsy syndrome	6.7e-06	7.15e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SOCS3—epilepsy syndrome	6.63e-06	7.08e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDC42—epilepsy syndrome	6.61e-06	7.06e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TSC2—epilepsy syndrome	6.56e-06	7e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AGT—epilepsy syndrome	6.55e-06	6.99e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—POMC—epilepsy syndrome	6.48e-06	6.92e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOE—epilepsy syndrome	6.42e-06	6.85e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AVP—epilepsy syndrome	6.4e-06	6.83e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL2—epilepsy syndrome	6.34e-06	6.77e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KDR—epilepsy syndrome	6.28e-06	6.71e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HES1—epilepsy syndrome	6.05e-06	6.46e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PRKCB—epilepsy syndrome	6.05e-06	6.46e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6ST—epilepsy syndrome	6.03e-06	6.43e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FYN—epilepsy syndrome	5.89e-06	6.28e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—H2AFX—epilepsy syndrome	5.87e-06	6.26e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MEF2C—epilepsy syndrome	5.86e-06	6.25e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGF2—epilepsy syndrome	5.73e-06	6.12e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.66e-06	6.04e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NGF—epilepsy syndrome	5.6e-06	5.97e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—POMC—epilepsy syndrome	5.51e-06	5.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR5—epilepsy syndrome	5.44e-06	5.81e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL2—epilepsy syndrome	5.39e-06	5.76e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HTR2A—epilepsy syndrome	5.33e-06	5.69e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RELA—epilepsy syndrome	5.32e-06	5.68e-05	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—epilepsy syndrome	5.23e-06	5.58e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MTOR—epilepsy syndrome	5.22e-06	5.57e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TSC2—epilepsy syndrome	5.06e-06	5.4e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AGT—epilepsy syndrome	5.06e-06	5.4e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOE—epilepsy syndrome	4.95e-06	5.29e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGF2—epilepsy syndrome	4.87e-06	5.2e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KDR—epilepsy syndrome	4.85e-06	5.18e-05	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.84e-06	5.17e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP3—epilepsy syndrome	4.8e-06	5.12e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.67e-06	4.99e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUN—epilepsy syndrome	4.66e-06	4.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.65e-06	4.97e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—epilepsy syndrome	4.53e-06	4.84e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RELA—epilepsy syndrome	4.52e-06	4.83e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MTOR—epilepsy syndrome	4.44e-06	4.73e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.4e-06	4.69e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—POMC—epilepsy syndrome	4.25e-06	4.54e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SRC—epilepsy syndrome	4.18e-06	4.46e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL2—epilepsy syndrome	4.16e-06	4.44e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.12e-06	4.4e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP3—epilepsy syndrome	4.08e-06	4.35e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.07e-06	4.35e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUN—epilepsy syndrome	3.96e-06	4.23e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—epilepsy syndrome	3.86e-06	4.12e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.76e-06	4.02e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—epilepsy syndrome	3.74e-06	3.99e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SRC—epilepsy syndrome	3.56e-06	3.79e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—epilepsy syndrome	3.55e-06	3.79e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RELA—epilepsy syndrome	3.49e-06	3.73e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—epilepsy syndrome	3.46e-06	3.7e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.43e-06	3.66e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.18e-06	3.39e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP3—epilepsy syndrome	3.15e-06	3.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUN—epilepsy syndrome	3.06e-06	3.27e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.98e-06	3.18e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.89e-06	3.08e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SRC—epilepsy syndrome	2.74e-06	2.93e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.67e-06	2.85e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—epilepsy syndrome	2.6e-06	2.77e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—epilepsy syndrome	2.21e-06	2.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.71e-06	1.82e-05	CbGpPWpGaD
